KR20200023163A - A composition for promoting the differentiation of human adipose derived stem cell - Google Patents

Abstract

The present invention relates to a cosmetic composition for increasing skin elasticity and reducing wrinkles, a food composition, a pharmaceutical composition, a quasi-drug composition, and a composition for promoting the differentiation of human adipose tissue-derived stem cells, each comprising, as an effective component, at least one substance selected from the group consisting of formononetin, emodin, artepillin c, carnosic acid, palmitamide, sodium guaiazulene sulfonate, caffeic acid, acetyl mandelic acid, laccaic acid, ubiquinone, hydroxycinnamic acid, xanthophyll, Magnoliae cortex extracts, aloe extracts, a fraction of Magnoliae cortex extracts, and a fraction of aloe extracts; and to a method of increasing skin elasticity, comprising a step of administering the composition to a non-human subject. The composition of the present invention promotes the differentiation of human adipose tissue-derived stem cells to adipocytes, thereby enhancing the subcutaneous fat layer structure, increasing skin elasticity, and reducing wrinkles, and thus may be used for an anti-aging purpose.

Description

Composition for promoting differentiation of human adipose stem cells {A composition for promoting the differentiation of human adipose derived stem cell}

The present invention is formononetin (Formononetin), Emodin (Emodin), Artepillin (Artepillin C), Carnosic acid (Carnosic acid), Palmitamide (Palmitamide), Sodium Guaiazulene Sulfonate (Sodium Guaiazulene Sulfonate), Caffeic Acid, Acetyl Mandelic Acid, Laccaic Acid, Ubiquinone, Hydroxycinnamic Acid, Xanthophyll, Xinhophyll, Aloe Extract, Aloe Extract Cosmetic composition, food composition, pharmaceutical composition, quasi-drug composition, human fat-derived stem cells comprising one or more substances selected from the group consisting of fractions of extracts and fractions of aloe extracts as active ingredients It relates to a composition for promoting differentiation and to a method for increasing skin elasticity, comprising administering the composition to a subject other than a human.

Adipose tissue plays a role in supporting the skin structure along with the muscles, and it is an important cell structurally so that the number of fat cells is 30-40% in number but 90% in volume. Subcutaneous adipose tissue decreases with aging of the individual, and accordingly, it is known that the elasticity of the skin decreases and wrinkles are generated a lot. In addition, when the fat is reduced by a sharp diet, the elasticity of the facial part decreases and wrinkles can be seen a lot. Therefore, increasing the volume in the skin by controlling the number of fat tissues that play an important role in maintaining the structure in the skin may be an improvement of skin elasticity and wrinkles. However, in the case of liposuction currently used for skin elasticity improvement, the transplanted stem cells have a very low in vivo engraftment rate, and need to be reoperated after a certain time and the transplanted fats aggregate. Therefore, it is essential to study the material that can strengthen the structure of the subcutaneous fat layer without such surgery.

On the other hand, the lips of the skin is not only the most moving parts of the body by repeating the constant contraction and expansion, it is always exposed to the extreme environment is easily affected by environmental factors such as ultraviolet, cold, dry. In addition, the lips have a different structure than normal skin, and their own defense ability is weak, and as they age, the volume decreases and wrinkles increase, thereby losing an attractive shape. Accordingly, in the case of lips, as in general skin, it is necessary to develop a composition having an excellent effect on volume and wrinkle care, but the currently developed technology is a technology that uses wrinkle improvement ingredients studied for facial skin as it is, and a temporary volume. There are only techniques that give an increase. The latter increase in volume is due to a stimulus response.

In recent studies on adipocytes or liposuction, adipose stem cells that are present in subcutaneous fat tissue and have differentiation ability into adipocytes have attracted attention. Adipokine, secreted by adipose-derived stem cells, is known to not only increase collagen synthesis in the dermal layer but also affect skin regeneration. In the case of a substance known to differentiate adipose progenitor cells into adipocytes, a result of targeting adipose progenitor cells of a mouse is low in efficiency when applied to human adipose derived stem cells.

Accordingly, the inventors of the present invention have made efforts to find a substance that effectively promotes the differentiation of fat-derived stem cells into adipocytes. As a result, formononetin ( Formononetin, Emodin, Artepillin C, Carnosic acid, Palmitamide, Sodium Guaiazulene Sulfonate, Caffeic Acid, Acetyl Mandelic Acid, Laccaic Acid, Ubiquinone, Hydroxycinnamic Acid, Xanthophyll, Thick Extract, or Aloe Extract It was confirmed that the present invention can be used for the purpose of increasing elasticity and improving wrinkles.

Korean Publication 10-2012-0140450 A

One object of the present invention is formononetin, (Emodin), Artemipillin (Artepillin C), Carnosic acid (Palmitamide), Sodium Guazulene sulfonate (Sodium) Guaiazulene Sulfonate, Caffeic Acid, Acetyl Mandelic Acid, Laccaic Acid, Ubiquinone, Hydroxycinnamic Acid, Xanthophyll, Xanthophyll, Thick Extract, It is to provide a cosmetic composition for enhancing skin elasticity and improving wrinkles, comprising as an active ingredient at least one material selected from the group consisting of aloe extracts, fractions of the thick extract and fractions of the aloe extracts.

Another object of the present invention is to formmononetin, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacaic acid, ubiquinone, hydroxycinnamic acid, It is to provide a food composition for increasing skin elasticity and improving wrinkles, which comprises at least one substance selected from the group consisting of xanthophyll, pak bak extract, aloe extract, fraction of pak pak extract and fraction of aloe extract.

Another object of the present invention is to formmononetin, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacaic acid, ubiquinone, hydroxycinnamic acid, It is to provide a pharmaceutical composition for increasing skin elasticity and improving wrinkles, comprising at least one substance selected from the group consisting of xanthophyll, pak hak extract, aloe extract, a fraction of hoo pak extract and a fraction of aloe extract.

Another object of the present invention is to formmononetin, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacaic acid, ubiquinone, hydroxycinnamic acid, It is to provide an quasi-drug composition for increasing skin elasticity and improving wrinkles, which comprises at least one substance selected from the group consisting of xanthophyll, pak pak extract, aloe extract, fraction of hoo pak extract and fraction of aloe extract.

Another object of the present invention is for formonenetine, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacaic acid, ubiquinone, hydroxycinnamic acid To provide a composition for promoting differentiation of human adipose-derived stem cells comprising at least one substance selected from the group consisting of, xanthophyll, huhu extract, aloe extract, fraction of huhu extract and fraction of aloe extract as an active ingredient. .

Yet another object of the present invention is to provide a method for increasing skin elasticity, comprising administering the composition to a subject other than a human.

This will be described in detail below. Meanwhile, each description and embodiment disclosed in the present application may be applied to each other description and embodiment. That is, all combinations of the various elements disclosed in this application are within the scope of the present application. In addition, the scope of the present application is not to be limited by the specific description described below.

One embodiment of the present invention is formononetin, (Emodin), Artepillin (Artepillin C), Carnosic acid (Palmitamide), Sodium Guazulene sulfonate (Sodium) Guaiazulene Sulfonate, Caffeic Acid, Acetyl Mandelic Acid, Laccaic Acid, Ubiquinone, Hydroxycinnamic Acid, Xanthophyll, Xanthophyll, Thick Extract, It provides a cosmetic composition for increasing skin elasticity and improving wrinkles, comprising as an active ingredient at least one material selected from the group consisting of aloe extracts, fractions of thick extracts and fractions of aloe extracts. The composition comprises one, two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen of the above substances. Dog or 16 substances may be included as an active ingredient.

One embodiment of the present invention may be a cosmetic composition for increasing lip skin elasticity and improving wrinkles, which comprises at least one substance selected from the group consisting of a thick leaf extract and a fraction of a thick leaf extract.

In addition, another embodiment of the present invention is the formmononetine, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacaic acid, ubiquinone, hydroxy Provided is a cosmetic composition for increasing skin elasticity and improving wrinkles, including a cosmetically acceptable salt of cinnamic acid or xanthophyll as an active ingredient.

In the present invention, "cosmetically acceptable salts" include formononetin, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacaic acid, ubiquinone In the form of a salt in which hydroxycinnamic acid or xanthophyll is combined with another substance, it means a substance which can exhibit a similar activity to the compound cosmetically, but is not limited thereto.

The inventors of the present invention intensively tried to develop a substance capable of activating and restoring the aged subcutaneous fat layer, and as a result, formononetin, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, cafe Acids, acetyl mandelic acid, lacaic acid, ubiquinone, hydroxycinnamic acid, xanthophyll, hickory extract and aloe extract have developed a substance that can promote the differentiation of human adipose derived stem cells into adipocytes. Through this it was found that the composition comprising the material can be used as a cosmetic composition for increasing skin elasticity and wrinkles. The skin elasticity and wrinkle improvement effect of the material is not known at all until now, it is very significant in that it was first developed by the present inventors.

The molecular formula of the term "formononetin" of the present invention is C ₁₆ H ₁₂ O ₄ , the molecular weight is 284.26, it may be represented by the formula (1) below.

[Formula 1]

Although the formmononetine of the present invention can be isolated from plants including licorice, it is not limited to its obtaining method, and chemically synthesized by methods known in the art or commercially available materials can be used.

The molecular formula of the term "Emodin" of the present invention is C ₁₅ H ₁₀ O ₅ , The molecular weight is 270.24, which can be represented by the following formula (2).

[Formula 2]

Emodine of the present invention is not limited to the method for obtaining the same, and chemically synthesized by a method known in the art, or a commercially available material may be used.

The molecular formula of the term "Artepillin C" of the present invention is C ₁₉ H ₂₄ O 3, the molecular weight is 300.40, it can be represented by the formula (3) below.

[Formula 3]

Artephylline C of the present invention is not limited to the method of obtaining the same, and chemically synthesized by a method known in the art, or a commercially available material may be used.

The molecular formula of the term "Carnosic acid" of the present invention is C ₂₀ H ₂₈ O ₄ , the molecular weight is 332.44, it may be represented by the formula (4).

[Formula 4]

The carnoic acid of the present invention is not limited to the method of obtaining the same, and chemically synthesized by a method known in the art, or a commercially available material may be used.

The term "palmitamide" of the present invention is a normal chain fatty acid amide having 16 carbon atoms, a molecular formula of C ₁₆ H ₃₃ NO, a molecular weight of 255, and may be represented by the following Chemical Formula 5.

[Formula 5]

Palmitamide of the present invention is not limited to its acquisition method, and chemically synthesized by methods known in the art, or commercially available materials may be used.

The molecular formula of the term "Sodium Guaiazulene Sulfonate" of the present invention is C ₁₅ H ₁₇ NaO ₃ S, the molecular weight is 300.35, it can be represented by the formula (6).

[Formula 6]

The sodium guazulene sulfonate of the present invention is not limited to its acquisition method, and chemically synthesized by a method known in the art, or a commercially available material can be used.

The molecular formula of the term "Caffeic Acid" of the present invention is C ₉ H ₈ O ₄ , the molecular weight is 180.157, it can be represented by the formula (7).

[Formula 7]

The caffeic acid of the present invention is not limited to the method of obtaining the same, and chemically synthesized by a method known in the art, or a commercially available material may be used.

The term "acetyl mandelic acid" of the present invention may be specifically "O-acetyl mandelic acid", the molecular formula is C ₁₀ H ₁₀ O ₄ , molecular weight is 194.186, It may be represented by the formula (8) below.

[Formula 8]

Acetyl mandelic acid of the present invention is not limited to its acquisition method, and may be chemically synthesized by a method known in the art, or a commercially available material may be used.

The term "Laccaic Acid" of the present invention is one of natural anthraquinones and is a dark red crystal produced by condensing secretions of Laccifer lacca Kerr , and is known to be mainly used as a dye. The lacaic acid is not particularly limited thereto, but may be lacaic acid A, B, C, D, E or F. In one embodiment of the present invention, 50506 (Natural red 25) manufactured by Sigma-Aldrich was used as the laccaic acid.

Lacaic acid of the present invention is not limited to the method for obtaining the same, and chemically synthesized by a method known in the art, or a commercially available material may be used.

The term "Ubiquinone" of the present invention is one of fat-soluble quinones and is a constituent of the electron transport system of mitochondria. Specifically, the ubiquinone may be ubiquinone (10), but is not limited thereto. In this case, the molecular formula is C ₅₉ H ₉₀ O ₄ , the molecular weight is 863.37, and may be represented by Formula 9 below.

[Formula 9]

The ubiquinone of the present invention is not limited to the method of obtaining the same, and chemically synthesized by a method known in the art, or a commercially available material can be used.

Molecular formula of the term "Hydroxycinnamic Acid" of the present invention is C ₉ H ₈ O ₃ , molecular weight is 164.158, the isomer according to the position of the -OH group directly substituted in the benzene ring (o-, m-, p-hydroxycinnamic acid) and isomers by double bonds (cis-type coumarinic acid and trans-type coumaric acid) may be included, and specifically, may be m-Coumaric acid, This is not particularly limited. The hydroxycinnamic acid may be represented by the following Formula 10.

[Formula 10]

The hydroxycinnamic acid of the present invention is not limited to its acquisition method, and chemically synthesized by a method known in the art, or a commercially available material can be used.

The term "Xanthophyll" of the present invention is a carotenoid-based oxycarotenoid pigment present in green parts of leaves, flowers, fruits, etc. of plants, and yellow, and the molecular formula is C ₄₀ H ₅₆ O ₂ , molecular weight is 569. . The xanthophyll may be specifically lutein, and may be represented by Formula 11 below.

[Formula 11]

Xanthophyll or lutein of the present invention is not limited to the method of obtaining the same, and chemically synthesized by a method known in the art, or a commercially available material may be used.

The formononetin, emodine, artepilin, carnosic acid, palmiamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, laccaic acid, ubiquinone, hydroxycinnamic acid or xanthophyll are in solvated forms. As well as may be present in unsolvated form. In addition, the compounds may exist in crystalline or amorphous form, and all such physical forms are included within the scope of the present invention.

In addition, it is obvious that the scope of the compounds includes not only the compound but also cosmetic, food and pharmaceutically acceptable salts thereof.

The term of the present invention "Magnolia (Magnoliae Cortex)" includes lignans and the essential oil to be dried stems and root bark of the magnolia magnolia plants, the main active ingredient. Takbak is known to have effects such as anti-inflammatory, analgesic, smooth muscle control and anti-ulcer. The grommets can be purchased commercially, or can be used without limitation to those collected or grown in nature.

The term " Aloe vera " of the present invention is a perennial plant belonging to the genus Lilies and Aloe, also called presbyopia. Its main active ingredients include aloe, aloe emodine, aloetin, alomitine, etc., and are known to act as antibacterial, antifungal and antitumor. The aloe may be purchased commercially, or may be used without limitation, collected or grown in nature.

The term "extract" of the present invention is a liquid component obtained by immersing a desired material in various solvents, and then extracting for a predetermined time at room temperature, low temperature or warm state, obtained by removing the solvent from the liquid component It means the result of solid content. In addition, in addition to the result, it can be comprehensively interpreted to include all of the dilution of the resultant, their concentrates, their modifiers, purified products and the like.

In the present invention, the extract may be a bakbak or aloe extract. The extract can be extracted from various organs of natural, hybrid, variegated plants, and can be extracted from plant tissues as well as roots, grounds, stems, leaves, flowers, trunks of fruits, bark of berries. The extract can be obtained by extraction with water or various organic solvents. At this time, the organic solvent to be used is not particularly limited as long as the extract can be obtained, but specifically, may be water, a polar solvent or a non-polar solvent, more specifically water, a lower alcohol having 1 to 6 carbon atoms ( Methanol, ethanol, propanol or butanol, and the like, and a mixed solvent thereof.

In addition, the method for obtaining the extract is not particularly limited as long as it can obtain the extract or aloe extract, specifically, the root, stem, leaves, fruit, flowers, dried products thereof, of the extract or aloe, Dipping the workpiece into the solvent, cold extraction method, extraction at room temperature, ultrasonic extraction method by applying ultrasonic waves, reflux extraction method using a reflux condenser can be used.

The term "fraction" of the present invention means the result obtained by performing the fractionation to separate a specific component or a specific component group from a mixture comprising various various components. In the present invention, the fraction may be a fraction of the hoo extract extract or a fraction of the aloe extract.

The fractionation method of obtaining the fraction in the present invention is not particularly limited as long as it can exhibit an increase in skin elasticity and wrinkle improvement, but may be performed according to a method commonly used in the art. For example, solvent fractionation is performed by treating various solvents, ultrafiltration fractionation is performed by passing through an ultrafiltration membrane having a constant molecular weight cut-off value, and separation according to various chromatography (size, charge, hydrophobicity or affinity). Chromatographic fractionation, and combinations thereof).

The kind of the fractionation solvent used to obtain the fraction in the present invention is not particularly limited, and any solvent known in the art may be used. Non-limiting examples of the fractionation solvents include polar solvents such as water, distilled water and alcohols; And nonpolar solvents such as hexane, ethyl acetate, chloroform, dichloromethane, and the like. These may be used alone or in combination of two or more thereof. When alcohol is used in the fractionation solvent, alcohols of C1 to C4 may be used.

The cosmetic composition of the present invention is a formmononetin, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, laccaic acid, ubiquinone, hydroxycinnamic acid, glass One or more substances selected from the group consisting of toffee, hulhu extract, aloe extract, fraction of hulhu extract and fraction of aloe extract may comprise 0.0005 to 10% by weight (w / w) based on the total weight of the composition, and To 0.001 to 5% by weight (w / w), but is not limited thereto.

In the present invention, the cosmetic composition may promote differentiation of human adipose derived stem cells into adipocytes. That is, the cosmetic composition may be to increase skin elasticity and improve wrinkles by promoting differentiation of human adipose derived stem cells into adipocytes.

The term "human adipose derived stem cell" of the present invention refers to a multipotent cell capable of differentiating into various cells of the body as a stem cell that can be collected from human adipose tissue. Adipose-derived stem cells are present in subcutaneous adipose tissue and have differentiation ability into adipocytes. Adipokine secreted by adipose-derived stem cells not only increases collagen synthesis in the dermal dermal layer, but also affects skin regeneration.

The term "adipose cell" of the present invention refers to a cell that stores fat in adipose tissue of an individual, and may specifically mean white adipocytes present in the subcutaneous fat layer, but is not limited thereto. Do not.

In one embodiment of the present invention, human adipose derived stem cells form formononetin, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacacaic acid, ubiquinone As a result of the treatment of hydroxycinnamic acid, xanthophyll, thick extract and aloe extract, it was confirmed that the differentiation of human adipose derived stem cells into adipocytes could be effectively promoted. Therefore, the composition of the present invention comprising the above materials can be used for anti-aging purposes by increasing the elasticity of the skin and improving wrinkles.

The term "increased skin elasticity" of the present invention means to increase the elasticity of the skin by strengthening the subcutaneous fat layer structure of the individual by using the composition of the present invention. The skin may be included without limitation, as long as the skin may have increased elasticity or wrinkles with the composition of the present invention.

The term "improvement" of the present invention means using the composition of the present invention to alleviate the symptoms of skin wrinkles in a subject.

In one embodiment of the present invention, the skin may be a lip skin, but is not limited thereto. The active ingredient of the cosmetic composition for increasing elasticity and improving wrinkles of the skin of the lips may be one or more substances selected from the group consisting of thick extracts, and fractions of thick extracts, but are not limited thereto.

Lips, unlike other skin areas, have no sebaceous glands and have a very thin stratum corneum. Currently, the volume and wrinkle improvement ingredients used for the lips have been applied to improve the dermal layer of the skin, and the subcutaneous fat enhancement technology that occupies the largest volume in the skin has a limitation that cannot be actively applied. In addition, considering that the stratum corneum is so thin that the penetration and delivery of the active ingredient will be easier than other skin areas, the volume improvement technique of the subcutaneous fat layer can be expected to be more effective in terms of volume and wrinkle improvement. The composition of the present invention is characterized by an excellent effect on such a skin of the lips. In one embodiment of the present invention, it was confirmed that the wrinkle improvement of the extract of the bakbak has an excellent effect on both the eyes and the lips, it was confirmed that the improvement rate and the improvement rate in the lips than the eyes.

The cosmetic composition for lip skin may be prepared in a formulation selected from the group consisting of lipstick, lip gloss, lip tint, and lip balm, but is not limited thereto.

In the present invention, the cosmetic composition is a solution, external ointment, cream, foam, nourishing longevity, softening longevity, pack, softening water, latex, makeup base, essence, soap, liquid detergent, bathing agent, sunscreen cream, sun oil, It may be prepared in a formulation selected from the group consisting of suspensions, emulsions, pastes, gels, lotions, powders, soaps, surfactant-containing cleansing, oils, powder foundations, emulsion foundations, wax foundations, patches and sprays, but It is not limited.

In addition, the cosmetic composition of the present invention may further include one or more cosmetically acceptable carriers formulated in general skin cosmetics, and as conventional components, for example, oil, water, surfactants, moisturizers, lower alcohols, Thickeners, chelating agents, pigments, preservatives, flavoring agents, and the like may be appropriately blended, but are not limited thereto.

The cosmetically acceptable carrier included in the cosmetic composition of the present invention varies depending on the dosage form.

When the formulation of the present invention is an ointment, paste, cream or gel, the carrier component is animal oil, vegetable oil, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc, zinc oxide or Mixtures of these may be used.

If the formulation of the invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate, polyamide powder or mixtures thereof may be used, in particular in the case of a spray additionally chloro Propellants such as fluorohydrocarbons, propane / butane or dimethyl ether.

When the formulation of the present invention is a solution or emulsion, solvents, solubilizers or emulsions are used as carrier components, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butylglycol oil may be used, in particular cottonseed oil, peanut oil, corn seed oil, olive oil, castor oil and sesame oil, glycerol aliphatic ester, polyethylene glycol or fatty acid ester of sorbitan may be used. have.

When the formulation of the present invention is a suspension, liquid carrier diluents such as water, ethanol or propylene glycol, suspending agents such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol esters and polyoxyethylene sorbitan esters, micro Crystalline cellulose, aluminum metahydroxy, bentonite, agar or tracant and the like can be used.

When the formulation of the present invention is a soap, alkali metal salts of fatty acids, fatty acid hemiester salts, fatty acid protein hydrolyzates, isethionates, lanolin derivatives, aliphatic alcohols, vegetable oils, glycerol, sugars and the like can be used as carrier components. have.

The cosmetic composition of the present invention is formononetin, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, laccaic acid, ubiquinone, hydroxycinnamic acid, xanthophyll Auxiliaries commonly used in addition to at least one substance selected from the group consisting of, extracts, aloe extracts, fractions of extracts of halo extracts and fractions of aloe extracts such as hydrophilic or lipophilic gelling agents, hydrophilic or lipophilic active agents, preservatives, antioxidants , Solvents, fragrances, fillers, blockers, pigments, odorants, dyes and the like.

Another embodiment of the present invention is a formmononetine, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacaic acid, ubiquinone, hydroxycinnamic acid, It provides a food composition for increasing skin elasticity and improving wrinkles, comprising at least one substance selected from the group consisting of xanthophyll, pak hak extract, aloe extract, a fraction of hoo pak extract, and a fraction of aloe extract. In the present invention, the composition may increase skin elasticity and improve wrinkles by promoting differentiation of human adipose derived stem cells into adipocytes.

The formmononetin, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacaic acid, ubiquinone, hydroxycinnamic acid, xanthophyll, hubac, aloe, Extracts, fractions, skin elasticity increase and improvement are as described above.

In one embodiment of the present invention, the skin may be a lip skin, but is not limited thereto. The active ingredient of the food composition for increasing elasticity and improving wrinkles of the skin of the lips may be one or more substances selected from the group consisting of thick extracts, and fractions of thick extracts, but are not limited thereto.

The present invention also relates to the formation of formmononetin, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacaic acid, ubiquinone, hydroxycinnamic acid or xanthophyll. Provided is a food composition for increasing skin elasticity and improving wrinkles, comprising a food acceptable salt as an active ingredient.

In the present invention, a "food acceptable salt" refers to formmononetin, emodine, artepilin, carnosic acid, palmiamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacacaic acid, ubiquinone In the form of a salt in which hydroxycinnamic acid or xanthophyll is combined with another substance, it means a substance which can exhibit similar activity to the compound in food terms.

The food composition of the present invention is a formmononetin, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacaic acid, ubiquinone, hydroxycinnamic acid, xanthophyll In addition to at least one substance selected from the group consisting of, a pak extract, aloe extract, a fraction of the pak extract, and a fraction of the aloe extract may include a food supplement acceptable food additive.

In the present invention, the "food supplement" means a component that can be added to food supplements, and can be appropriately selected and used by those skilled in the art to be added to prepare a health functional food of each formulation. Examples of food additives include flavors such as various nutrients, vitamins, minerals (electrolytes), synthetic and natural flavors, colorants and fillers, pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protective colloidal thickeners. , pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated beverages, and the like, but is not limited thereto.

Functional food composition of the present invention may include a health functional food. In the present invention, the "health functional food" refers to a food prepared and processed in the form of tablets, capsules, powders, granules, liquids and pills using raw materials or ingredients having useful functions for the human body. Here, the term "functionality" means obtaining useful effects on health purposes such as nutrient control or physiological effects on the structure and function of the human body. The health functional food of the present invention can be prepared by a method commonly used in the art, and the preparation can be prepared by adding raw materials and ingredients commonly added in the art. In addition, the formulation of the health functional food may also be prepared without limitation as long as the formulation is recognized as a health functional food. Food composition of the present invention can be prepared in various forms of formulation, unlike the general medicine has the advantage that there is no side effect that can occur when taking long-term use of the drug as a raw material of food, and excellent portability, Health functional foods can be taken as supplements to increase skin elasticity and improve wrinkles.

There is no restriction on the form that the health functional food of the present invention can take, and may include all foods in a conventional meaning, and may be mixed with terms known in the art such as functional foods. In addition, the health functional food of the present invention may be prepared by mixing known additives with other appropriate auxiliary ingredients that may be included in the food according to the choice of those skilled in the art. Examples of foods that can be added include meat, sausages, breads, chocolates, candy, snacks, confectionery, pizza, ramen, other noodles, gums, dairy products, including ice cream, various soups, beverages, teas, drinks, alcoholic beverages and Vitamin complexes; It also includes foods used as feed for animals.

Another embodiment of the present invention is a formmononetine, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacaic acid, ubiquinone, hydroxycinnamic acid, It provides a pharmaceutical composition for increasing skin elasticity and improving wrinkles, comprising one or more substances selected from the group consisting of xanthophyll, hoo hoo extract, aloe extract, fraction of hoo hoo extract and fraction of aloe extract. In the present invention, the composition may increase skin elasticity and improve wrinkles by promoting differentiation of human adipose derived stem cells into adipocytes. The formmononetin, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacaic acid, ubiquinone, hydroxycinnamic acid, xanthophyll, hubac, aloe, Extracts, fractions, skin elasticity increase and improvement are as described above.

In one embodiment of the present invention, the skin may be a lip skin, but is not limited thereto. The active ingredient of the pharmaceutical composition for increasing elasticity and improving wrinkles of the skin of the lips may be one or more substances selected from the group consisting of a pak extract, and a fraction of the pak extract, but is not limited thereto.

The present invention also relates to the formation of formmononetin, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacaic acid, ubiquinone, hydroxycinnamic acid or xanthophyll. It provides a pharmaceutical composition for increasing skin elasticity and improving wrinkles, including a pharmaceutically acceptable salt as an active ingredient.

In the present invention, a "pharmaceutically acceptable salt" refers to formmononetin, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacaic acid, ubiquinone In the form of a salt in which hydroxycinnamic acid or xanthophyll is combined with another substance, it means a substance which can exhibit similar activity to the compound.

The pharmaceutical composition of the present invention may also be used as a single agent, and may be prepared and used as a complex preparation, further comprising a drug known to have an effect of increasing skin elasticity and improving wrinkles, and by formulating it with a pharmaceutically acceptable carrier or excipient. It may be prepared in unit dose form or incorporated into a multi-dose container.

The pharmaceutical composition may be administered in a pharmaceutically effective amount. The term “pharmaceutically effective amount” means an amount sufficient to treat the disease at a reasonable benefit / risk ratio applicable to medical treatment, and the effective dose level is dependent on the individual type and severity, age, sex, activity of the drug, drug Sensitivity, time of administration, route of administration and rate of release, duration of treatment, factors including concurrent use of drugs, and other factors well known in the medical arts.

Another embodiment of the present invention is a formmononetine, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacaic acid, ubiquinone, hydroxycinnamic acid, It provides a quasi-drug composition for increasing skin elasticity and improving wrinkles, comprising at least one substance selected from the group consisting of xanthophyll, pak hak extract, aloe extract, a fraction of hoo pak extract, and a fraction of aloe extract. In the present invention, the composition may increase skin elasticity and improve wrinkles by promoting differentiation of human adipose derived stem cells into adipocytes. The formmononetin, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacaic acid, ubiquinone, hydroxycinnamic acid, xanthophyll, hubac, aloe, Extracts, fractions, skin elasticity increase and improvement are as described above.

In one embodiment of the present invention, the skin may be a lip skin, but is not limited thereto. The active ingredient of the quasi-drug composition for increasing the elasticity of the skin and improving wrinkles may be one or more substances selected from the group consisting of hoo-pak extract, and fractions of hoo-bak extract, but are not limited thereto.

The present invention also relates to the formation of formmononetin, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacaic acid, ubiquinone, hydroxycinnamic acid or xanthophyll. Provided is an quasi-drug composition for increasing skin elasticity and improving wrinkles, including a pharmaceutically acceptable salt as an active ingredient. The "pharmaceutically acceptable salts" are as described above.

The quasi-drug composition of the present invention may further include a pharmaceutically acceptable carrier, excipient or diluent as necessary in addition to the above components. The pharmaceutically acceptable carriers, excipients or diluents are not limited so long as they do not impair the effects of the present invention and include, for example, fillers, extenders, binders, wetting agents, disintegrants, surfactants, lubricants, sweeteners, fragrances, preservatives, and the like. It may include.

The "pharmaceutically acceptable carrier" may refer to a carrier, excipient or diluent that does not impair the biological activity and properties of the compound to be injected, without stimulating the organism, specifically, non-naturally occuring carrier). The type of the carrier usable in the present invention is not particularly limited, and any carrier can be used as long as it is a conventionally used and pharmaceutically acceptable carrier in the art. Non-limiting examples of the carrier include saline, sterile water, Ringer's solution, buffered saline, albumin injection solution, dextrose solution, maltodextrin solution, glycerol, ethanol and the like. These may be used alone or in combination of two or more thereof.

The composition comprising a pharmaceutically acceptable carrier may be in various oral or parenteral formulations. When formulated, diluents or excipients such as fillers, extenders, binders, wetting agents, disintegrating agents and surfactants are usually used. Specifically, solid preparations for oral administration include tablets, pills, powders, granules, capsules and the like, and such solid preparations include at least one excipient such as starch, calcium carbonate, sucrose, lactose, It can be prepared by mixing gelatin and the like. In addition to simple excipients, lubricants such as magnesium stearate, talc can also be used. Oral liquid preparations include suspensions, solvents, emulsions, and syrups.In addition to commonly used simple diluents such as water and liquid paraffin, various excipients such as wetting agents, sweeteners, fragrances, and preservatives may be included. have. Formulations for parenteral administration include sterile aqueous solutions, non-aqueous solvents, suspensions, emulsions, lyophilized preparations and suppositories. As the non-aqueous solvent and suspending agent, propylene glycol, polyethylene glycol, vegetable oils such as olive oil, injectable esters such as ethyl oleate and the like can be used. As the base of the suppository, Uittepsol, macrogol, Tween 61, cacao butter, laurin butter, glycerogelatin and the like can be used.

The quasi-drug composition of the present invention may be exemplified by disinfecting detergents, shower foams, ointments, wet tissues, coatings, etc., but is not limited thereto. Formulation methods, dosages, methods of use, components, etc. of the quasi-drugs are well known in the art. It may be appropriately selected from the description of.

In addition, the quasi-drug composition of the present invention can be used in a method for improving skin wrinkles, comprising applying to the skin of an individual. The subject includes, without limitation, mammals including rats, livestock, humans and the like.

Another embodiment of the present invention is a formmononetin, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacaic acid, ubiquinone, hydroxycinnamic acid It provides a composition for promoting differentiation of human adipose-derived stem cells, comprising at least one substance selected from the group consisting of xanthophyll, pakbak extract, aloe extract, a fraction of pakbak extract and a fraction of aloe extract as an active ingredient. In the present invention, the composition may increase skin elasticity and improve wrinkles by promoting differentiation of human adipose derived stem cells into adipocytes. The formmononetin, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacaic acid, ubiquinone, hydroxycinnamic acid, xanthophyll, hubac, aloe, Extracts, fractions, skin elasticity increase and improvement are as described above.

Another aspect of the invention provides a method of increasing skin elasticity comprising administering the composition to a subject other than a human.

As used herein, the term "administration" means introducing a composition of the present invention to a patient in any suitable manner, and the route of administration of the composition may be administered via any general route as long as it can reach the desired tissue. have. Intraperitoneal administration, intravenous administration, intramuscular administration, subcutaneous administration, intradermal administration, oral administration, topical administration, intranasal administration, but is not limited thereto. Due to the characteristics of the composition of the present invention having an effect on improving skin elasticity and improving wrinkles, the route of administration of the composition may be applied to the skin.

The composition of the present invention may be administered daily or intermittently, and the number of administrations per day may be administered once or divided into two or three times. In addition, the composition of the present invention can be used alone or in combination with other drug treatments to enhance skin elasticity and improve wrinkles. In consideration of all the above factors, it is important to administer an amount that can obtain the maximum effect in a minimum amount without side effects, and can be easily determined by those skilled in the art.

As used herein, the term "individual" refers to all animals including rats, mice, domestic animals, and the like, including humans, which have reduced skin elasticity, wrinkled skin, or may occur. Specifically, it may be a mammal including a human.

The composition of the present invention can be used for anti-aging purposes by enhancing the subcutaneous fat layer structure, promoting skin elasticity and improving wrinkles by promoting the differentiation of human adipose derived stem cells into adipocytes.

Figure 1 shows the result of staining lipids in adipocytes differentiated with oil red o after treatment with formononetin, acetyl mandelic acid and hubac extract to human adipose derived stem cells.
Figure 2 is a formmononetin, emodine, artephylline, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacaic acid, ubiquinone, hydroxycinnamic acid, xanthophyll, thick extract And it shows quantitatively the relative differentiation rate of human adipose derived stem cells treated with aloe extract.
Figure 3 shows the results of comparing the number of people around the eyes and lip wrinkles of the bakbak extract.
Figure 4a shows the persistence of lip wrinkle improvement until the 12th week of the subject 1 when the bakbak extract treatment, Figure 4b shows the persistence of lip wrinkle improvement until the week 12 of the subject 2.
Figure 5 shows the results of comparing the improvement of the eye area and lip wrinkles of the bakbak extract and the conventional wrinkle improvement material Asiaticoside.

Hereinafter, the present invention will be described in detail by the following examples. However, the following examples are only for illustrating the present invention, and the scope of the present invention is not limited by the following examples.

Example 1 Preparation of Thick and Aloe Extracts

Example magnolia extract of the present embodiment was purchased from borak Co. (Gyeonggi Mars, Republic of Korea), using a powder of magnolia (Magnoliae Cortex) in DPG, DMSO, etc. dissolved in a solvent, a 0.2μm filtered liquid by filtering a syringe filter Magnolia Extract It was.

In order to prepare the aloe extract of the present Example Aloe Vera (Aloe Vera) was purchased from the domestic farm, and extracted once with 70% methanol at 1:10 ratio.

Example 2: Confirmation of the effect of promoting the differentiation of human fat-derived stem cells of formononetin, acetyl mandelic acid, and hubac extract

Human adipose derived stem cells were purchased from Lonza Inc (Lonza Inc, Walkersvile, MD, USA) and cultured according to Lonza's experimental guidelines. Differentiation into adipocytes was tested using differentiation medium recommended by Lonza. As a positive control, rosiglitazone 1uM was used as the differentiation medium. To induce differentiation of adipocyte-derived stem cells into adipocytes, three to five days after incubation of the cells, the cell culture medium was removed and treated with formononetin, acetyl mandelic acid, and hubac extract and positive control for 14 days.

After 14 days of differentiation into adipocytes, the cell culture was removed, the cells were washed with phosphate buffer (DPBS) and the cells were fixed with 10% formalin. The fixed cells were observed under a microscope by staining lipids in adipocytes differentiated with Oil Red O. As a result, the differentiation effect of fat-derived stem cells into adipocytes was higher when treated with Formononetin, Acetyl Mandelic acid, and Thick extract, which are representative substances, compared with only the differentiation medium (negative control). It can be seen that excellent (Fig. 1).

Example 3: Quantitative Confirmation of the Differentiation Promoting Effects of 12 Compounds Including Formononetine, Thick Extracts and Aloe Extracts on Human Adipose Stem Cells

In the same manner as in Example 2, 12 kinds of compounds including formonenetine, thick gourd extract and aloe extract were treated to cultured human adipose derived stem cells, and then eluted with oil red o stained with 100% isopropanol solution. Absorbance was measured and quantified at the wavelength, and the result is shown in FIG. 2. From this, 14 kinds of substances including the formonenetine of the present invention showed a significant increase in relative differentiation rate compared to the negative control treated with differentiation medium, respectively, promoting the differentiation of adipose derived stem cells into adipocytes, and kaperpherol (kaempherol) Compared with non-differentiated material such as), it was confirmed that it can effectively promote differentiation into adipocytes. Therefore, the composition of the present invention comprising the above substance can be used for anti-aging purposes to promote differentiation of adipose derived stem cells and increase subcutaneous adipocytes, thereby increasing skin elasticity and improving wrinkles.

Example 4: Confirmation of the improvement effect of the skin wrinkles of the lip balm extract

In order to confirm the skin wrinkle improvement effect of the huhu extract extract prepared in Example 1, the huhu extract extract was treated to wrinkles of the skin of the lips and the skin of the subjects (total number of subjects: 12).

The wrinkles of the skin of the lips were measured by designating the most protruding portion of the lower lip by a certain length through Janus photographing, and obtaining the standard deviation of the contrast value. The standard deviation range of the contrast value was 3 to 12, and the more the deep wrinkles, the larger the standard deviation was confirmed. The wrinkles of the skin under the eye were measured by calculating the area of wrinkles in the Janus wrinkle analysis program, that is, through Janus photography. The value of the wrinkles was confirmed to represent a range of 7 to 44.

The change in the lip wrinkle value of 1 or more and the change in the fold wrinkle value of 4 or more were classified as improved results. The classification criterion was confirmed that the numerical value that can clearly distinguish the improvement with the naked eye is 2 lip wrinkles, 8 wrinkles under the eyes, because 1/2 of this value was selected as a criterion for improvement.

As a result of treatment of the lip balm extract on the lip skin, it was confirmed that the improvement of the number of subjects (8) was maximized at the 4th week and maintained similarly until the 12th week. As a result of treatment of the fold extract under the wrinkles under the eyes, it was confirmed that the improvement in the proportion similar to the lip skin up to 4 weeks, the increase in the number of subjects improved by the 12th week, although the low rate of increase (Fig. 3).

In addition, it was confirmed that the wrinkle improvement effect is maintained until the 12th week after treatment of the lip balm extract on the subject's lips skin, and the elasticity of the lips skin is improved (FIG. 4). This is a result confirming that the extract of bakbak promotes the differentiation of fat stem cells and increases subcutaneous fat cells, which is actually effective in improving skin wrinkles and elasticity.

As a result of comparing the anti-wrinkle effect of Asiaticoside, which is a conventional anti-wrinkle material, with the skin of the lips and the skin under the eyes, the thick extract extract has a higher rate of improvement and improvement in the wrinkles of the lips skin than the skin under the eyes, and Asiaticoside is better than the skin of the lips. It was confirmed that the improvement rate and the improvement rate in the wrinkles of the skin under the eyes (FIG. 5).

Through this, it can be seen that the extract of bakbak has an effect of improving the wrinkles of the skin, in particular, it is more effective in improving the wrinkles of the skin of the lips.

From the above description, those skilled in the art will understand that the present invention can be implemented in other specific forms without changing the technical spirit or essential features. In this regard, the embodiments described above are to be understood in all respects as illustrative and not restrictive. The scope of the present invention should be construed that all changes or modifications derived from the meaning and scope of the following claims and equivalent concepts rather than the detailed description are included in the scope of the present invention.

Claims (23)

Formononetin, Emodin, Artepillin C, Carnosic acid, Palmitamide, Sodium Guaiazulene Sulfonate, Caffeic acid ( Fraction of Caffeic Acid, Acetyl Mandelic Acid, Laccaic Acid, Ubiquinone, Hydroxycinnamic Acid, Xanthophyll, Thick Extract, Aloe Extract, Thick Extract And at least one substance selected from the group consisting of fractions of aloe extract as an active ingredient, cosmetic composition for increasing skin elasticity and improving wrinkles.
According to claim 1, wherein the skin is lips skin, cosmetic composition for increasing skin elasticity and wrinkles.
The cosmetic composition according to claim 2, wherein the active ingredient of the cosmetic composition for increasing elasticity and improving wrinkles of the lip skin comprises one or more substances selected from the group consisting of thick extract and a thin extract.
The cosmetic composition according to claim 2, wherein the cosmetic composition for lip skin is a formulation selected from lipstick, lip gloss, lip tint, or lip balm.
The method according to claim 1, wherein the formmononetin, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, lacaic acid, ubiquinone, hydroxycinnamic acid or xanthophyll Cosmetic composition containing a cosmetically acceptable salt as an active ingredient.
The cosmetic composition of claim 1, wherein the substance is included in an amount of 0.0005 to 10% by weight (w / w) based on the total weight of the composition.
The cosmetic composition of claim 1, wherein the extract is extracted with water, C1 to C6 alcohol, or a mixed solvent thereof.
The cosmetic composition of claim 1, wherein the substance promotes differentiation of human adipose derived stem cells into adipocytes.
According to claim 1, wherein the composition is a flexible cosmetic (nutrient emulsion), astringent lotion, nourishing cosmetics, nourishing cream, massage cream, essence, pack, skin adhesive patch, skin adhesive gel, powder, ointment, suspension, emulsion, It is a formulation selected from a spray or cosmetic liquid, cosmetic composition.
Formononetin, Emodin, Artepillin C, Carnosic acid, Palmitamide, Sodium Guaiazulene Sulfonate, Caffeic acid ( Fractions of Caffeic Acid, Acetyl Mandelic Acid, Laccaic Acid, Ubiquinone, Hydroxycinnamic Acid, Xanthophyll, Thick Extract, Aloe Extract, Thick Extract And at least one substance selected from the group consisting of a fraction of aloe extract as an active ingredient, food composition for increasing skin elasticity and improving wrinkles.
The food composition of claim 10, wherein the skin is lips skin.
The food composition of claim 11, wherein the active ingredient of the food composition for increasing elasticity and improving wrinkles of the skin of the lip comprises one or more substances selected from the group consisting of a pear extract, and a fraction of the pear extract.
12. The composition of claim 10, wherein the formononetin, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, laccaic acid, ubiquinone, hydroxycinnamic acid or xanthophyll Food composition comprising a food acceptable salt as an active ingredient.
Formononetin, Emodin, Artepillin C, Carnosic acid, Palmitamide, Sodium Guaiazulene Sulfonate, Caffeic acid ( Fractions of Caffeic Acid, Acetyl Mandelic Acid, Laccaic Acid, Ubiquinone, Hydroxycinnamic Acid, Xanthophyll, Thick Extract, Aloe Extract, Thick Extract And at least one substance selected from the group consisting of fractions of aloe extract as an active ingredient, skin elasticity increase and wrinkle improvement pharmaceutical composition.
The pharmaceutical composition according to claim 14, wherein the skin is lips skin.
The pharmaceutical composition of claim 15, wherein the active ingredient of the pharmaceutical composition for increasing elasticity and improving wrinkles of the skin of the lip comprises one or more substances selected from the group consisting of a pear extract, and a fraction of the pear extract.
15. The composition according to claim 14, wherein the formononetin, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, laccaic acid, ubiquinone, hydroxycinnamic acid or xanthophyll A pharmaceutical composition comprising a pharmaceutically acceptable salt of the active ingredient.
Formononetin, Emodin, Artepillin C, Carnosic acid, Palmitamide, Sodium Guaiazulene Sulfonate, Caffeic acid ( Fractions of Caffeic Acid, Acetyl Mandelic Acid, Laccaic Acid, Ubiquinone, Hydroxycinnamic Acid, Xanthophyll, Thick Extract, Aloe Extract, Thick Extract And at least one substance selected from the group consisting of a fraction of aloe extract as an active ingredient, the quasi-drug composition for increasing skin elasticity and improving wrinkles.
The quasi-drug composition according to claim 18, wherein the skin is lips skin.
20. The quasi-drug composition according to claim 19, wherein the active ingredient of the quasi-drug composition for increasing elasticity and improving wrinkles of the lip skin comprises one or more substances selected from the group consisting of thick extracts and fractions of thick extracts.
19. The composition of claim 18, wherein the formononetin, emodine, artepilin, carnosic acid, palmitamide, sodium guazulene sulfonate, caffeic acid, acetyl mandelic acid, laccaic acid, ubiquinone, hydroxycinnamic acid or xanthophyll A quasi-drug composition comprising a pharmaceutically acceptable salt of the active ingredient.
Formononetin, Emodin, Artepillin C, Carnosic acid, Palmitamide, Sodium Guaiazulene Sulfonate, Caffeic acid ( Fractions of Caffeic Acid, Acetyl Mandelic Acid, Laccaic Acid, Ubiquinone, Hydroxycinnamic Acid, Xanthophyll, Thick Extract, Aloe Extract, Thick Extract And at least one substance selected from the group consisting of fractions of aloe extract as an active ingredient, the composition for promoting differentiation of human adipose derived stem cells.
Formononetin, Emodin, Artepillin C, Carnosic acid, Palmitamide, Sodium Guaiazulene Sulfonate, Caffeic acid ( Fractions of Caffeic Acid, Acetyl Mandelic Acid, Laccaic Acid, Ubiquinone, Hydroxycinnamic Acid, Xanthophyll, Thick Extract, Aloe Extract, Thick Extract And administering to a subject, except a human, a composition comprising at least one substance selected from the group consisting of fractions of aloe extract as an active ingredient, skin elasticity.

Images